Nanotechnology for angiogenesis: opportunities and challenges

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Vascular Biology

Background:

• Angiogenesis is vital for embryonic development and implicated in diseases like cancer and wound healing.
• Pharmaceutical research focuses on stimulating or inhibiting angiogenesis for therapeutic benefit.
• Nanotechnology has emerged as a significant tool in medical applications, with nanomedicines gaining regulatory approval.

Purpose of the Study:

• To review nanotechnology-based strategies for controlling angiogenesis.
• To cover various nanoparticle types used in angiogenesis modulation.
• To highlight the potential of nanoparticles in theranostics and imaging.

Main Methods:

• Review of literature on nanotechnology applications in angiogenesis.
• Detailed examination of lipid-based, carbon-based, polymeric, inorganic, and metallic nanoparticles.
• Discussion of nanoparticle-mediated theranostic and imaging approaches.

Main Results:

• Nanoparticles offer versatile approaches for both stimulating and inhibiting angiogenesis.
• Diverse nanoparticle formulations (lipid, carbon, polymer, inorganic, metallic) are explored.
• Nanoparticles can facilitate theranostic and imaging applications in angiogenesis research.
• Some nanoparticle preparations exhibit a dose-dependent bimodal effect on angiogenesis.

Conclusions:

• Nanotechnology provides powerful tools for precise control over angiogenesis.
• Nanoparticle-based therapies hold significant potential for treating angiogenesis-related diseases.
• Future research should leverage nanoparticles for advanced angiogenesis modulation and diagnostics.